Award
Delivery Order #75N98027F00001
Synthesis of GMP Ketanserin Task Order under Long-Term Bulk Drug IDIQ Contract
Buyer
National Institutes of Health
Award Amount
$687,612.00
Ceiling
$687,612.00
Awarded
October 20, 2026
Period of Performance
Oct 20, 2026 – Jan 30, 2028
Identifier
75N98027F00001
NAICS
541715
This award represents a delivery order under a definitive indefinite-delivery indefinite-quantity (IDIQ) contract focused on the cGMP synthesis of bulk drug substances. The recipient, Benuvia Operations, LLC, specializes in the production of pharmaceutical-grade active ingredients, and this task order specifically involves the synthesis of GMP-grade ketanserin, a pharmaceutical compound. The contract is a vital component of the agency's long-term acquisition strategy to secure high-quality pharmaceutical substances, ensuring compliance with regulatory standards for medical applications. The scope includes the synthesis, quality control, and timely delivery of ketanserin according to cGMP guidelines. This delivery order was issued under a competitive and structured IDIQ contract awarded previously to Benuvia, allowing streamlined procurements within the defined ordering period. The duration of this task order spans over a year, with potential extension aligning with the parent contract's multi-year timeframe. The contract enhances supply chain reliability for critical pharmaceutical materials and underscores the agency's commitment to supporting pharmaceutical manufacturing capabilities in the public sector.
Description
TASK ORDER 2, SYNTHESIS OF GMP KETANSERIN